Please wait a minute...
European Journal of Gynaecological Oncology  2017, Vol. 38 Issue (4): 638-641    DOI: 10.12892/ejgo3973.2017
Case Report Previous articles | Next articles
Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma: a case report
L. Di Benedetto1, *(), A. Guarino1, M. Mallozzi1, D. Caserta1
1 Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea Hospital, Faculty of Medicine and Psychology, University of Rome "Sapienza", Rome, Italy
Download:  PDF(100KB)  ( 52 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Endometriosis is a chronic disease that affects women of reproductive age. Malignant transformation in endometriosis is considered to be an unusual event, only occurring in 0.7–0.1% of cases. However the association between endometriosis and endometrial cancer is not well defined. Also in literature, rare cases of uterine sarcoma, about 3% of all uterine malignancies, associated with endometriosis have been reported. The authors report a case of a 47-years-old Italian woman with histologic diagnosis of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and undifferentiated endometrial sarcoma. Therefore there have been few studies addressing the relationship between endometrial stromal sarcomas (ESS), and endometriosis. Novel scientific findings are necessary to investigate a possible common pathway and an effective treatment, although complete tumor resection can reduce the recurrence rate.
Key words:  Endometriosis      Endometrial stromal sarcomas      Endometrial cancer     
Published:  10 August 2017     
*Corresponding Author(s):  L. DI BENEDETTO     E-mail:  luisadibenedetto@outlook.it

Cite this article: 

L. Di Benedetto, A. Guarino, M. Mallozzi, D. Caserta. Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma: a case report. European Journal of Gynaecological Oncology, 2017, 38(4): 638-641.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo3973.2017     OR     https://ejgo.imrpress.com/EN/Y2017/V38/I4/638

[1] Burak Tatar. Risk of nodal metastasis associated with lymphovascular space invasion in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 850-854.
[2] Jaswinder Chalia, Musse Hussein, Mariya Farooqui, Jordan Mattson, Sally A. Mullany, Molly E. Klein, Boris Winterhoff, Mahmoud A. Khalifa. Concurrent immunohistochemical testing of L1CAM and MMR proteins adds value in risk stratification of endometrial cancer: a proof of concept[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 887-892.
[3] Felix Chan, Cherynne Yuin Mun Johansson. Single-site robotic-assisted hysterectomy and sentinel lymph node mapping for low-risk endometrial cancer: surgical technique and preliminary outcomes[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 966-972.
[4] Englert-Golon Monika, Słopień Radosław, Smolarek Natalia, Burchardt Bartosz, Sajdak Stefan. Synchronous ovarian, endometrial and cervical cancer—case report[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1093-1094.
[5] Laura Baquedano Mainar, Javier Navarro Sierra, Leticia Alvarez Sarrado, Yasmina José Gutiérrez, Marta Lamarca Ballestero, Patricia Rubio Cuesta, Ana C. Ruiz Peña, Andrea Espiau Romera. Clinical and demographic factors in endometrial and ovary carcinoma: synchronous carcinoma vs stage IIIA endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 643-648.
[6] Reem D. Mahmood, Robert D. Morgan, Tine Descamps, Claire Mitchell, Jurjees Hasan, Nerissa Mescallado, Lisa Barraclough, Kate Haslett, Jacqueline Livsey, Emma J. Crosbie, Richard J. Edmondson, Gordon C. Jayson, Andrew R. Clamp. Sequential chemotherapy-radiotherapy as adjuvant treatment of high-risk endometrial carcinoma: a retrospective review of the Manchester experience[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 673-681.
[7] Woraphot Chaowawanit, Vicki Campbell, Emily Wilson, Naven Chetty, Lewis Perrin, Nisha Jagasia, Sinead Barry. Retrospective review of sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging during minimally invasive surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 694-702.
[8] Hao Lin, Hung-Chun Fu, Fu-Tsai Kung, Yu-Jen Chen, Chan-Chao Chang Chien, Chen-Hsuan Wu, Ching-Chou Tsai, Yu-Che Ou. A comparison of laparoscopic and open surgery for early stage endometrial cancer with analysis of prognostic factors: a propensity score matching study[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 703-710.
[9] Tomoko Sakamoto Taniguchi, Shinichi Komiyama, Masaru Nagashima, Mineto Morita. Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 752-756.
[10] Erdem Cubukcu, Ahmet Bilgehan Sahin, Fatma Oz Atalay, Birol Ocak, Mine Ozsen, Candan Demiroz Abakay, Kemal Ozerkan, Ulviyya Hasanzade, Merve Mesohorli, Adem Deligonul, Hakan Ozan, Turkkan Evrensel. The Ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 775-781.
[11] Nikolaos Giannakopoulos, Ivana Virijevic, Merit Kullinger. Isolated vulvar metastasis after robot-assisted laparoscopic hysterectomy for low grade, early stage endometrial cancer: a case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 418-424.
[12] Shahzarul Fazril Lin, Zainab Yahaya, Nuraini Ramli, Habibah Abdul Hamid. Synchronous endometrial and ovarian carcinoma (SEOC): case series and literature review[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 434-440.
[13] Mehmet Sait Bakır, Özer Birge, Ceyda Karadag, Selen Doğan, Hasan Aykut Tuncer, Tayup Simsek. Clinicopathological risk factors and survival analysis of ovarian cancer with synchronous endometrial cancer diagnosed after surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 499-505.
[14] Sahin Lacin, Gozde Elif Tasar, Alp Usubutun, Zafer Arık, Deniz Yüce, Mehmet Çoşkun Salman, Ayşe Kars. The prognostic significance of microsatellite status and its relationship with tumor-infiltrating lymphocyte in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 541-547.
[15] Laura M. Harbin, Laurel K. Berry, Amy E. Wahlquist, Joshua Richmond, Whitney S. Graybill, Matthew F. Kohler, William T. Creasman. Tumor proximity to serosal surface as an independent prognostic factor in FIGO stage 1 endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 574-579.
No Suggested Reading articles found!